Editorial: Machine learning approaches to antimicrobials: discovery and resistance

• Shira L. Broschat,
• Shira L. Broschat,
• Shira L. Broschat,
• Shirley W. I. Siu,
• Shirley W. I. Siu,
• Cesar de la Fuente-Nunez,
• Cesar de la Fuente-Nunez,
• Cesar de la Fuente-Nunez,
• Cesar de la Fuente-Nunez,
• Cesar de la Fuente-Nunez

Affiliations

Shira L. Broschat

School of Electrical Engineering and Computer Science, Washington State University, Pullman, WA, United States

Shira L. Broschat

Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA, United States

Shira L. Broschat

Paul G. Allen School for Global Health, Washington State University, Pullman, WA, United States

Shirley W. I. Siu

Centre for Artificial Intelligence Driven Drug Discovery, Macao Polytechnic University, Macao, Macao SAR, China

Shirley W. I. Siu

Faculty of Applied Sciences, Macao Polytechnic University, Macao, Macao SAR, China

Cesar de la Fuente-Nunez

Machine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States

Cesar de la Fuente-Nunez

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, United States

Cesar de la Fuente-Nunez

Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, United States

Cesar de la Fuente-Nunez

Department of Chemistry, University of Pennsylvania, Philadelphia, PA, United States

Cesar de la Fuente-Nunez

0Penn Institute for Computational Science, University of Pennsylvania, Philadelphia, PA, United States